
Bloom Pharma Private Limited
About Bloom Pharma Private Limited
Data last updated:
Bloom Pharma Private Limited is a private limited company based in Nashik, Maharashtra, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 23 December 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2003PTC143607. Its GSTIN is 27AACCB3091M1ZH (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹9.3 Lakh. It is led by directors including Atul Namdeo Shinde and Narendra Madhukar Sonawane.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at G – 13 Sanjivani Sankulgole Colony, Nashik, Maharashtra, India – 422001.
As per the financials filed for FY 2024, the company reported a revenue of ₹68.59 Lakh, a growth of 38% compared to the previous year. For the same year it recorded a net loss of ₹31,174 (net margin -0.5%) and EBITDA of -₹12,865 (EBITDA margin -0.2%). Revenue has declined at a compounded annual rate (CAGR) of 15% over three years and 3% over five years.
The company has about 1 employee on its provident fund (EPFO) records.
As per MCA filings, the company has satisfied charges of ₹34 Lakh on record. Court records list 3 cases involving the company, including 3 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Bloom Pharma Private Limited's registered office is in Nashik, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressG – 13 Sanjivani Sankulgole Colony, Nashik, Maharashtra, India – 422001
- IndustryHealthcare, Medical Equipment Retail & Distribution
To see the full contact details of Bloom Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Bloom Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Bloom Pharma Private Limited, buy the company report.
Financials of Bloom Pharma Private Limited
FY 2024 filings availableBloom Pharma Private Limited reported revenue of ₹68.59 Lakh (up 38% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 38% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 3%. EBITDA rose 90% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹12,865 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹31,174 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.2% | ||||
| Net Profit Margin | -0.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bloom Pharma Private Limited, buy the company report.
Board of directors of Bloom Pharma Private Limited
Bloom Pharma has 5 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Atul Namdeo Shinde | Director | 23 Dec 2003 | 22 Years 10 Months | Current |
| Narendra Madhukar Sonawane | Director | 23 Dec 2003 | 22 Years 10 Months | Current |
| Karan Narendra Sonawane | Director | 04 Jul 2011 | 15 Years 3 Months | Current |
| Sandhya Narendra Sonawane | Director | 04 Jul 2011 | 15 Years 3 Months | Current |
| Nutan Sharad Rajbhoj | Director | 23 Dec 2003 | 22 Years 10 Months | Current |
Auditor
Bloom Pharma Private Limited is audited by Prasad Bhatt & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Prasad Bhatt & Associates | FY 2023 | 123662W |
Shareholding
The shareholding of Bloom Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Bloom Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 14 Jan 2009 | 10140476 | Uco Bank | ₹25 Lakh | Satisfied | |
| 14 Dec 2004 | 90141409 | Uco Bank | ₹9 Lakh | Satisfied |
To see the full charge records of Bloom Pharma Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Bloom Pharma Private Limited has 3 court cases on record: 3 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 3 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (S) | Filed against the company by Ipca Laboratories Limited | Disposed |
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Ipca Laboratories Limited | Disposed |
| Bombay High Court | Court case (LPETN) | Filed against the company by Ipca Laboratories Limited | Disposed |
To see the full case history of Bloom Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bloom Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Bloom Pharma Private Limited has a workforce of 1 employees on its EPFO records as of Mar 27, 2024, across 1 active EPFO establishment.
GST
Bloom Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCB3091M1ZH | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Bloom Pharma Private Limited, buy the company report.
Recent activity
Bloom Pharma Private Limited has 5 board changes on record since 2003: 5 appointments. The latest: Karan Narendra Sonawane was appointed as Director on 04 Jul 2011.
Frequently asked questions
Bloom Pharma is an active private limited company based in Nashik, Maharashtra, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 23 December 2003 (23+ years old) and is registered under CIN U24230MH2003PTC143607.
Bloom Pharma has 5 current directors:
- Atul Namdeo Shinde - Director
- Narendra Madhukar Sonawane - Director
- Karan Narendra Sonawane - Director
- Sandhya Narendra Sonawane - Director
- Nutan Sharad Rajbhoj - Director
The latest financial statements of Bloom Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Bloom Pharma is 27AACCB3091M1ZH, registered in Maharashtra.
The CIN (Corporate Identification Number) of Bloom Pharma is U24230MH2003PTC143607. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bloom Pharma has 3 court cases on record: 3 filed against it.
Bloom Pharma was incorporated on 23 December 2003, making it 23+ years old. It is registered with the Registrar of Companies, Mumbai.
Karan Narendra Sonawane was appointed as Director on 04 Jul 2011. Sandhya Narendra Sonawane was appointed as Director on 04 Jul 2011. Atul Namdeo Shinde was appointed as Director on 23 Dec 2003. Bloom Pharma has 5 board changes on record in total.
The registered office of Bloom Pharma is at G – 13 Sanjivani Sankulgole Colony, Nashik, Maharashtra, India – 422001.
Bloom Pharma operates in the healthcare industry, in the medical equipment retail and distribution segment.

